Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian L Harris

Showing results (391-400 of 443) with videos related to

Pageof 45
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 2008
BHLHB2 controls Bdnf promoter 4 activity and neuronal excitabilityXueying Jiang, Feng Tian, Yang Du, et al.
BMC Cancer|May 27, 2011
Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomasMonika Golinska, Helen Troy, Yuen-Li Chung, et al.
Molecular Cancer Research : MCR|October 1, 2003
Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitroPaul J Adam, Joanne Berry, Julie A Loader, et al.
Nature Medicine|August 9, 2011
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonizationManav Korpal, Brian J Ell, Francesca M Buffa, et al.
Cancer Research|August 2, 2011
DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivoJi-Liang Li, Richard C A Sainson, Chern Ein Oon, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1α and Relation to Clinical ResponseDaniele Generali, Alfredo Berruti, Maria Rosa Cappelletti, et al.
Breast Cancer Research and Treatment|January 8, 2010
Synergistic activity of letrozole and sorafenib on breast cancer cellsMara A Bonelli, Claudia Fumarola, Roberta R Alfieri, et al.
The Journal of Clinical Investigation|January 5, 2012
Human CHCHD4 mitochondrial proteins regulate cellular oxygen consumption rate and metabolism and provide a critical role in hypoxia signaling and tumor progressionJun Yang, Oliver Staples, Luke W Thomas, et al.
Oncotarget|June 23, 2014
ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancerKatharina Feldinger, Daniele Generali, Gabriela Kramer-Marek, et al.
The Journal of Biological Chemistry|January 23, 2013
Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptorPat Whiteman, Beatriz Hernandez de Madrid, Paul Taylor, et al.
Pageof 45

Showing results (391-400 of 443) with videos related to

Sort By:
Pageof 45
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 2008
BHLHB2 controls Bdnf promoter 4 activity and neuronal excitabilityXueying Jiang, Feng Tian, Yang Du, et al.
BMC Cancer|May 27, 2011
Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomasMonika Golinska, Helen Troy, Yuen-Li Chung, et al.
Molecular Cancer Research : MCR|October 1, 2003
Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitroPaul J Adam, Joanne Berry, Julie A Loader, et al.
Nature Medicine|August 9, 2011
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonizationManav Korpal, Brian J Ell, Francesca M Buffa, et al.
Cancer Research|August 2, 2011
DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivoJi-Liang Li, Richard C A Sainson, Chern Ein Oon, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1α and Relation to Clinical ResponseDaniele Generali, Alfredo Berruti, Maria Rosa Cappelletti, et al.
Breast Cancer Research and Treatment|January 8, 2010
Synergistic activity of letrozole and sorafenib on breast cancer cellsMara A Bonelli, Claudia Fumarola, Roberta R Alfieri, et al.
The Journal of Clinical Investigation|January 5, 2012
Human CHCHD4 mitochondrial proteins regulate cellular oxygen consumption rate and metabolism and provide a critical role in hypoxia signaling and tumor progressionJun Yang, Oliver Staples, Luke W Thomas, et al.
Oncotarget|June 23, 2014
ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancerKatharina Feldinger, Daniele Generali, Gabriela Kramer-Marek, et al.
The Journal of Biological Chemistry|January 23, 2013
Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptorPat Whiteman, Beatriz Hernandez de Madrid, Paul Taylor, et al.
Pageof 45